150 related articles for article (PubMed ID: 15753655)
1. Connecting reovirus oncolysis and Ras signaling.
Marcato P; Shmulevitz M; Lee PW
Cell Cycle; 2005 Apr; 4(4):556-9. PubMed ID: 15753655
[TBL] [Abstract][Full Text] [Related]
2. Unshackling the links between reovirus oncolysis, Ras signaling, translational control and cancer.
Shmulevitz M; Marcato P; Lee PW
Oncogene; 2005 Nov; 24(52):7720-8. PubMed ID: 16299532
[TBL] [Abstract][Full Text] [Related]
3. Exploring host factors that impact reovirus replication, dissemination, and reovirus-induced cell death in cancer versus normal cells in culture.
Shmulevitz M; Lee PW
Methods Mol Biol; 2012; 797():163-76. PubMed ID: 21948476
[TBL] [Abstract][Full Text] [Related]
4. Ras transformation mediates reovirus oncolysis by enhancing virus uncoating, particle infectivity, and apoptosis-dependent release.
Marcato P; Shmulevitz M; Pan D; Stoltz D; Lee PW
Mol Ther; 2007 Aug; 15(8):1522-30. PubMed ID: 17457318
[TBL] [Abstract][Full Text] [Related]
5. Reovirus oncolysis: the Ras/RalGEF/p38 pathway dictates host cell permissiveness to reovirus infection.
Norman KL; Hirasawa K; Yang AD; Shields MA; Lee PW
Proc Natl Acad Sci U S A; 2004 Jul; 101(30):11099-104. PubMed ID: 15263068
[TBL] [Abstract][Full Text] [Related]
6. Reovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathway.
Twigger K; Roulstone V; Kyula J; Karapanagiotou EM; Syrigos KN; Morgan R; White C; Bhide S; Nuovo G; Coffey M; Thompson B; Jebar A; Errington F; Melcher AA; Vile RG; Pandha HS; Harrington KJ
BMC Cancer; 2012 Aug; 12():368. PubMed ID: 22920673
[TBL] [Abstract][Full Text] [Related]
7. Oncolytic reovirus induces intracellular redistribution of Ras to promote apoptosis and progeny virus release.
Garant KA; Shmulevitz M; Pan L; Daigle RM; Ahn DG; Gujar SA; Lee PW
Oncogene; 2016 Feb; 35(6):771-82. PubMed ID: 25961930
[TBL] [Abstract][Full Text] [Related]
8. Proteolytic disassembly is a critical determinant for reovirus oncolysis.
Alain T; Kim TS; Lun X; Liacini A; Schiff LA; Senger DL; Forsyth PA
Mol Ther; 2007 Aug; 15(8):1512-21. PubMed ID: 17519890
[TBL] [Abstract][Full Text] [Related]
9. Strategic Combinations: The Future of Oncolytic Virotherapy with Reovirus.
Zhao X; Chester C; Rajasekaran N; He Z; Kohrt HE
Mol Cancer Ther; 2016 May; 15(5):767-73. PubMed ID: 27197256
[TBL] [Abstract][Full Text] [Related]
10. Expression of HBX, an oncoprotein of hepatitis B virus, blocks reoviral oncolysis of hepatocellular carcinoma cells.
Park EH; Koh SS; Srisuttee R; Cho IR; Min HJ; Jhun BH; Lee YS; Jang KL; Kim CH; Johnston RN; Chung YH
Cancer Gene Ther; 2009 May; 16(5):453-61. PubMed ID: 19096445
[TBL] [Abstract][Full Text] [Related]
11. The viral tropism of two distinct oncolytic viruses, reovirus and myxoma virus, is modulated by cellular tumor suppressor gene status.
Kim M; Williamson CT; Prudhomme J; Bebb DG; Riabowol K; Lee PW; Lees-Miller SP; Mori Y; Rahman MM; McFadden G; Johnston RN
Oncogene; 2010 Jul; 29(27):3990-6. PubMed ID: 20473328
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in the Most Oncolytic Reovirus Strain Confer Enhanced Cell Attachment, Transcription, and Single-Step Replication Kinetics.
Mohamed A; Smiley JR; Shmulevitz M
J Virol; 2020 Jan; 94(4):. PubMed ID: 31776267
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of oncolytic reovirus against human breast cancer cells.
Hata Y; Etoh T; Inomata M; Shiraishi N; Nishizono A; Kitano S
Oncol Rep; 2008 Jun; 19(6):1395-8. PubMed ID: 18497942
[TBL] [Abstract][Full Text] [Related]
14. Oncolytic viral therapy for human pancreatic cancer cells by reovirus.
Etoh T; Himeno Y; Matsumoto T; Aramaki M; Kawano K; Nishizono A; Kitano S
Clin Cancer Res; 2003 Mar; 9(3):1218-23. PubMed ID: 12631628
[TBL] [Abstract][Full Text] [Related]
15. Internalization of oncolytic reovirus by human dendritic cell carriers protects the virus from neutralization.
Ilett EJ; Bárcena M; Errington-Mais F; Griffin S; Harrington KJ; Pandha HS; Coffey M; Selby PJ; Limpens RW; Mommaas M; Hoeben RC; Vile RG; Melcher AA
Clin Cancer Res; 2011 May; 17(9):2767-76. PubMed ID: 21389099
[TBL] [Abstract][Full Text] [Related]
16. Reovirus oncolysis of human breast cancer.
Norman KL; Coffey MC; Hirasawa K; Demetrick DJ; Nishikawa SG; DiFrancesco LM; Strong JE; Lee PW
Hum Gene Ther; 2002 Mar; 13(5):641-52. PubMed ID: 11916487
[TBL] [Abstract][Full Text] [Related]
17. The oncolytic effects of reovirus in canine solid tumor cell lines.
Igase M; Hwang CC; Coffey M; Okuda M; Noguchi S; Mizuno T
J Vet Med Sci; 2015 May; 77(5):541-8. PubMed ID: 25648933
[TBL] [Abstract][Full Text] [Related]
18. The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus.
Strong JE; Coffey MC; Tang D; Sabinin P; Lee PW
EMBO J; 1998 Jun; 17(12):3351-62. PubMed ID: 9628872
[TBL] [Abstract][Full Text] [Related]
19. Potential for Improving Potency and Specificity of Reovirus Oncolysis with Next-Generation Reovirus Variants.
Mohamed A; Johnston RN; Shmulevitz M
Viruses; 2015 Dec; 7(12):6251-78. PubMed ID: 26633466
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma.
Errington F; White CL; Twigger KR; Rose A; Scott K; Steele L; Ilett LJ; Prestwich R; Pandha HS; Coffey M; Selby P; Vile R; Harrington KJ; Melcher AA
Gene Ther; 2008 Sep; 15(18):1257-70. PubMed ID: 18401435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]